0.96
-1.85%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About AquaBounty Technologies
From its filings with the US Securities and Exchange Commission
AquaBounty Technologies is based in Harvard, Massachusetts and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker AQB. The SEC classifies its business as fishing, hunting and trapping. In the fiscal year to 31 December 2023, it reported revenue of $2.5m. By business, Ge Atlantic Salmon Member brought in 94.3% of revenue, followed by Non Ge Atlantic Salmon Fry Member at 5.0% and Other Revenue Member at 0.7%. By region, U [S] accounted for 94.3%, followed by C [A] at 5.7%.
AquaBounty has historically pursued a growth strategy that included the construction of large-scale recirculating aquaculture system (“RAS”) farms for producing our genetically engineered Atlantic salmon (the “GE Atlantic salmon”). We had commenced construction of a 10,000 metric ton farm in Pioneer, Ohio (the “Ohio Farm Project”), but paused the construction in June 2023, as the cost estimate to complete the farm continued to substantially increase due to inflation and other factors. Further, these cost increases impaired our ability to pursue municipal bond financing, which was a necessary component of our funding strategy. We subsequently engaged an investment bank to pursue a range of funding and strategic alternatives, and to assist management in the prioritization of our core assets. These efforts resulted in the sale of our grow-out farm in Indiana (“Indiana Farm”) in July 2024, recurring sales throughout 2024 and 2025 of selected equipment originally intended for the Ohio Farm Project (“Ohio Equipment Assets”), and the sale of our Canadian subsidiary, including the broodstock farms owned by the Canadian subsidiary in Prince Edward Island, Canada (“Canadian Farms”), and our intellectual property for the GE Atlantic salmon, along with trademarks and patents (“Corporate IP”) in March 2025. After completion of these transactions, our primary remaining asset is our investment in the Ohio Farm Project, consisting of the remaining Ohio Equipment Assets and the land and construction in process (the “Ohio Farm Site”).
Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 9 Jan 2017
- Employees
- 64
- Website
- aquabounty.com ↗
- Head office
- 233 AYER ROAD SUITE 4, HARVARD, MA, 01451
- Incorporated in
- DE
- Classification
- Fishing, Hunting and Trapping
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Sylvia WulfNon-Executive Chairman of the Board, since 2019$248,496
- Mr. David FrankInterim Chief Executive Officer, Chief Financial Officer, Treasurer, since 2007$334,750
- Mr. Graydon BenslerNon-Executive Independent Director
- Mr. Braeden LichtiNon-Executive Independent Director
- Mr. Rick SterlingNon-Executive Independent Director$22,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 26
- Environment
- 6
- Social
- 33
- Governance
- 40
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- AquaBounty Technologies Inc. is headquartered in Maynard, Massachusetts.
- The company employs 64 full-time employees.
- AquaBounty offers AAdvantage Salmon (AAS) for land-based facilities.
Weaknesses
- The company's IPO was in 2017, indicating a relatively recent market entry.
- AquaBounty focuses on research and development of antifreeze proteins (AFPs).
- The company's business model relies on land-based aquaculture systems.
Opportunities
- AAdvantage Salmon can be grown in land-based facilities closer to consumers.
- The company offers disease-free, antibiotic-free salmon with a reduced carbon footprint.
- Land-based recirculating aquaculture systems avoid marine ecosystem pollution.
Threats
- The company's focus on antifreeze proteins (AFPs) may limit market diversification.
- Land-based aquaculture systems require significant infrastructure investment.
- Competition in the biotechnology sector may impact market share.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.